Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel: Efficacy and Toxicity in a Real-World Setting

CD19 CAR-T therapy has revolutionized the management of high-risk and relapsed/refractory (R/R) large B-cell lymphoma (LBCL) but remains limited by significant toxicities leading to morbidity/mortality and high resource utilization. Single-arm studies have suggested differences in efficacy and toxic...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.2131-2131
Hauptverfasser:	Portuguese, Andrew J, Albittar, Aya, Liang, Emily C, Huang, Jennifer J., Hirayama, Alexandre V, Kimble, Erik L, Iovino, Lorenzo, Poh, Christina, Gopal, Ajay K, Shadman, Mazyar, Till, Brian G, Kiem, Hans-Peter, Milano, Filippo, Chapuis, Aude G, Otegbeye, Folashade, Cassaday, Ryan D, Maloney, David G, Gauthier, Jordan
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!